/Companies

Priothera Ltd.

3 known investors

Find your way into Priothera Ltd.

Sign up to see every warm intro you have to Priothera Ltd.

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Priothera Ltd. team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Priothera is a clinical-stage biotech developing mocravimod (an S1P receptor modulator) for hematologic malignancies such as acute myeloid leukemia. The company focuses on drug development for cancer patients undergoing hematopoietic stem cell transplantation.

Founders & leadership

FGFlorent Gros
Florent GrosChief Executive Officer and Founder
SOStephan Oehen
Stephan OehenChief Operating Officer and FounderStephan Oehen is a drug developer with over 25 years in biotech and pharmaceutical R&D across autoimmunity, transplantation, inflammation, dermatology, and vaccines, with a background in immunology and prior experience spanning early research through late-stage development and lifecycle management.
BS
Brice SuireChief Financial Officer and Founder
NCNigel Clark
Nigel ClarkChief Business Officer
JHJens Hasskarl
Jens HasskarlChief Medical Officer

Investors · 3

Frequently asked questions

What does Priothera Ltd. do?
Priothera is a clinical-stage biotech developing mocravimod (an S1P receptor modulator) for hematologic malignancies such as acute myeloid leukemia. The company focuses on drug development for cancer patients undergoing hematopoietic stem cell transplantation.
Who founded Priothera Ltd.?
Priothera Ltd. was founded by Florent Gros, Stephan Oehen, Brice Suire.
Who are Priothera Ltd.'s investors?
Priothera Ltd.'s investors include Fountain Healthcare Partners, HealthCap, 4see Ventures.